SCHEMBL14733192

SCHEMBL14733192

CO/C=C1/C(=O)Oc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 1/20 0.47
TOP2A P11388 1/20 0.47
MIF P14174 1/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MCL1 Q07820 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ACHE P22303 1/20 0.42
LMNA P02545 2/20 0.40
STK17B O94768 5/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29391221 1.00 TOP1 (0.47) TOP1TOP2AMIFALDH1A1SMN1; SMN2
SCHEMBL30671756 1.00 TOP1 (0.47) TOP1TOP2AMIFALDH1A1SMN1; SMN2
SCHEMBL30671755 1.00 TOP1 (0.47) TOP1TOP2AMIFALDH1A1SMN1; SMN2
SCHEMBL29800479 1.00 TOP1 (0.47) TOP1TOP2AMIFALDH1A1SMN1; SMN2
SCHEMBL16561703 1.00 TOP1 (0.47) TOP1TOP2AMIFALDH1A1SMN1; SMN2
SCHEMBL711838 1.00 TOP1 (0.47) TOP1TOP2AMIFALDH1A1SMN1; SMN2
SCHEMBL8447771 0.81 ALDH1A1 (0.50) TOP1TOP2AMIFALDH1A1SMN1; SMN2
SCHEMBL8448279 0.78 TOP1 (0.38) TOP1ALDH1A1STK17BMAPTTDP1
SCHEMBL6813657 0.76 MIF (0.46) MIFALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8445731 0.75 TOP1 (0.56) TOP1TOP2AMIFALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023203574-A1 A PROCESS FOR PREPARATION OF AZOXYSTROBIN NACL INDUSTRIES LIMITED (IN) 2023-10-26 WO claimed
CN-116924997-A Preparation method of azoxystrobin intermediate 江苏剑牌农化股份有限公司 2023-10-24 CN claimed
US-12024492-B2 Process for preparation of azoxystrobin and intermediates thereof UPL LTD (IN) 2024-07-02 US disclosed
US-12024492-B2 Process for preparation of azoxystrobin and intermediates thereof UPL LTD (IN) 2024-07-02 US disclosed
WO-2023203574-A1 A PROCESS FOR PREPARATION OF AZOXYSTROBIN NACL INDUSTRIES LIMITED (IN) 2023-10-26 WO disclosed
WO-2023203574-A1 A PROCESS FOR PREPARATION OF AZOXYSTROBIN NACL INDUSTRIES LIMITED (IN) 2023-10-26 WO disclosed
CN-116924997-A Preparation method of azoxystrobin intermediate 江苏剑牌农化股份有限公司 2023-10-24 CN disclosed
US-20220185784-A1 PROCESS FOR PREPARATION OF AZOXYSTROBIN AND INTERMEDIATES THEREOF UPL LTD (IN) 2022-06-16 US disclosed
WO-2020212919-A1 PROCESS FOR PREPARATION OF AZOXYSTROBIN AND INTERMEDIATES THEREOF UPL LIMITED (IN) 2020-10-22 WO disclosed
EP-3476837-A1 METHOD FOR PREPARING AZOXYSTROBIN INTERMEDIATES CAC Nantong Chemical Co., Ltd. (CN) 2019-05-01 EP disclosed
US-10253001-B2 Method for preparing azoxystrobin and its intermediates NUTRICHEM COMPANY LIMITED (CN) 2019-04-09 US disclosed
US-20180141918-A1 METHOD FOR PREPARING AZOXYSTROBIN AND ITS INTERMEDIATES NUTRICHEM COMPANY LIMITED (CN) 2018-05-24 US disclosed
US-9920015-B2 Methods for preparing azoxystrobin and intermediate thereof NUTRICHEM COMPANY LIMITED (CN) 2018-03-20 US disclosed
US-9920015-B2 Methods for preparing azoxystrobin and intermediate thereof NUTRICHEM COMPANY LIMITED (CN) 2018-03-20 US disclosed
US-20160200687-A1 Methods for Preparing Azoxystrobin and Intermediate Thereof SHANGYU NUTRICHEM CO., LTD. (CN) 2016-07-14 US disclosed
US-20160200687-A1 Methods for Preparing Azoxystrobin and Intermediate Thereof SHANGYU NUTRICHEM CO., LTD. (CN) 2016-07-14 US disclosed
EP-3042896-A1 METHODS FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF Nutrichem Company Limited (CN) 2016-07-13 EP disclosed
WO-2015032192-A1 METHODS FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF 北京颖泰嘉和生物科技有限公司 (CN) 2015-03-12 WO disclosed
WO-2014203270-A2 PROCESS FOR THE PREPARATION OF ACRYLATE DERIVATIVES BHAGIRADHA CHEMICALS & INDUSTRIES LIMITED (IN) 2014-12-24 WO disclosed
WO-2013026391-A1 SYNTHESIS METHOD OF AZOXYSTROBIN AND EXCLUSIVE INTERMEDIATE IN THE SYNTHESIS THEREOF 重庆紫光化工股份有限公司 (CN) 2013-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160200687-A1 Methods for Preparing Azoxystrobin and Intermediate Thereof AZI2, CYP2B6, CYP4B1 TOP1 240/4885TOP2A 127/4885MIF 364/4885
US-20180141918-A1 METHOD FOR PREPARING AZOXYSTROBIN AND ITS INTERMEDIATES AZI2, CYP2B6, CYP4B1 TOP1 301/4885TOP2A 170/4885MIF 484/4885
US-12024492-B2 Process for preparation of azoxystrobin and intermediates thereof NISCH, STS, SNX2 TOP1 1029/4885TOP2A 1369/4885MIF 1773/4885
US-10253001-B2 Method for preparing azoxystrobin and its intermediates AZI2, CYP2B6, CYP4B1 TOP1 301/4885TOP2A 170/4885MIF 484/4885
US-20220185784-A1 PROCESS FOR PREPARATION OF AZOXYSTROBIN AND INTERMEDIATES THEREOF NISCH, STS, SNX2 TOP1 1029/4885TOP2A 1369/4885MIF 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.